Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Microparticle Injectables Market Size study, by Therapeutic Application (Chronic Diseases, Autoimmune Diseases, Hormone Related Disorders, Oncology, Others ) by Administration Site (Central Nervous System, Skin, Musculoskeletal, Targeted Organs) by Distribution Channel (Medical Hospital Pharmacy, Retail Pharmacy ) and Regional Forecasts 2022-2028

  • BIZ4950693
  • 200 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Microparticle Injectables Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Microparticle Injectables are broadly used constituents of multiparticulate drug delivery systems, which offers both technological and therapeutic advantages. Microparticle-based formulations can increase the stability of drugs, enzymes to be delivered and released in a sustained manner at the target site. Growing prevalence of chronic diseases and rising research and development activities in Medical Equipment Technologies are key drivers for the growth of Microparticle Injectables market. For instance, according to Centers for disease Control and Preventation- as of 2020, 6 in 10 US adults have chronic diseases and chronic disease is leading contributor of the Nation’s USD 3.8 Trillion spending in Annual Health Care Costs. Also, as per World Health Organization (WHO) – as of 2021, Noncommunicable diseases (NCDs) kill 41 million people each year, accounting for around 71% of all global deaths. Furthermore, more than 15 million people between the ages of 30 and 69 years die due to Noncommunicable diseases. In recent events in December 2021 Baxter International Inc, an American global MedTech company, has acquired Hill-Rom, an American medical technology provider. Baxter paid USD 10.5 billion for the acquisition. Also, with growing geriatric population and rising healthcare industry in emerging economies, the adoption & demand for Microparticle Injectables is likely to increase the market growth during the forecast period. However, availability of other alternatives and infections risk associated with microparticle injectables impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Microparticle Injectables Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to presence of key and leading market players in the region in addition to a developed healthcare infrastructure in the region. Whereas Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast period 2022-2028. Factors such as growing healthcare sector and rising prevalence of chronic diseases in the region would create lucrative growth prospects for the Microparticle Injectables Market across Asia-Pacific region.

Major market player included in this report are:

Chevron Oronite

Lubrizol Life Science

Baxter International

Sandoz

Eli Lilly and Company

Pfizer

Evonik

Oakwood Labs

GP Pharm

Buckman Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Application:

Chronic Diseases

Autoimmune Diseases

Hormone Related Disorders

Oncology

Others

By Administration Site:

Central Nervous System

Skin

Musculoskeletal

Targeted Organs

By Distribution Channel:

Medical Hospital Pharmacy

Retail Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Microparticle Injectables Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. Microparticle Injectables Market, by Region, 2020-2028 (USD Billion)

1.2.2. Microparticle Injectables Market, by Therapeutic Application, 2020-2028 (USD Billion)

1.2.3. Microparticle Injectables Market, by Administration Site, 2020-2028 (USD Billion)

1.2.4. Microparticle Injectables Market, by Distribution Channel, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Microparticle Injectables Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Microparticle Injectables Market Dynamics

3.1. Microparticle Injectables Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Growing prevalence of chronic diseases.

3.1.1.2. Rising R&D in Medical equipment technology.

3.1.2. Market Challenges

3.1.2.1. Availability of other alternatives.

3.1.2.2. Risk of infections associated with microparticle injectables

3.1.3. Market Opportunities

3.1.3.1. Rising geriatric population.

3.1.3.2. Growing healthcare industry in emerging economies.

Chapter 4. Global Microparticle Injectables Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Microparticle Injectables Market, by Therapeutic Application

6.1. Market Snapshot

6.2. Global Microparticle Injectables Market by Therapeutic Application, Performance - Potential Analysis

6.3. Global Microparticle Injectables Market Estimates & Forecasts by Therapeutic Application 2019-2028 (USD Billion)

6.4. Microparticle Injectables Market, Sub Segment Analysis

6.4.1. Chronic Diseases

6.4.2. Autoimmune Diseases

6.4.3. Hormone Related Disorders

6.4.4. Oncology

6.4.5. Others

Chapter 7. Global Microparticle Injectables Market, by Administration Site

7.1. Market Snapshot

7.2. Global Microparticle Injectables Market by Administration Site, Performance - Potential Analysis

7.3. Global Microparticle Injectables Market Estimates & Forecasts by Administration Site 2019-2028 (USD Billion)

7.4. Microparticle Injectables Market, Sub Segment Analysis

7.4.1. Central Nervous System

7.4.2. Skin

7.4.3. Musculoskeletal

7.4.4. Targeted Organs

Chapter 8. Global Microparticle Injectables Market, by Distribution Channel

8.1. Market Snapshot

8.2. Global Microparticle Injectables Market by Distribution Channel, Performance - Potential Analysis

8.3. Global Microparticle Injectables Market Estimates & Forecasts by Distribution Channel 2019-2028 (USD Billion)

8.4. Microparticle Injectables Market, Sub Segment Analysis

8.4.1. Medical Hospital Pharmacy

8.4.2. Retail Pharmacy

Chapter 9. Global Microparticle Injectables Market, Regional Analysis

9.1. Microparticle Injectables Market, Regional Market Snapshot

9.2. North America Microparticle Injectables Market

9.2.1. U.S. Microparticle Injectables Market

9.2.1.1. Therapeutic Application breakdown estimates & forecasts, 2019-2028

9.2.1.2. Administration Site breakdown estimates & forecasts, 2019-2028

9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2028

9.2.2. Canada Microparticle Injectables Market

9.3. Europe Microparticle Injectables Market Snapshot

9.3.1. U.K. Microparticle Injectables Market

9.3.2. Germany Microparticle Injectables Market

9.3.3. France Microparticle Injectables Market

9.3.4. Spain Microparticle Injectables Market

9.3.5. Italy Microparticle Injectables Market

9.3.6. Rest of Europe Microparticle Injectables Market

9.4. Asia-Pacific Microparticle Injectables Market Snapshot

9.4.1. China Microparticle Injectables Market

9.4.2. India Microparticle Injectables Market

9.4.3. Japan Microparticle Injectables Market

9.4.4. Australia Microparticle Injectables Market

9.4.5. South Korea Microparticle Injectables Market

9.4.6. Rest of Asia Pacific Microparticle Injectables Market

9.5. Latin America Microparticle Injectables Market Snapshot

9.5.1. Brazil Microparticle Injectables Market

9.5.2. Mexico Microparticle Injectables Market

9.6. Rest of The World Microparticle Injectables Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Chevron Oronite

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Lubrizol Life Science

10.2.3. Baxter International

10.2.4. Sandoz

10.2.5. Eli Lilly and Company

10.2.6. Pfizer

10.2.7. Evonik

10.2.8. Oakwood Labs

10.2.9. GP Pharm

10.2.10. Buckman Laboratories

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Microparticle Injectables Market, report scope

TABLE 2. Global Microparticle Injectables Market estimates & forecasts by Region 2019-2028 (USD Billion)

TABLE 3. Global Microparticle Injectables Market estimates & forecasts by Therapeutic Application 2019-2028 (USD Billion)

TABLE 4. Global Microparticle Injectables Market estimates & forecasts by Administration Site 2019-2028 (USD Billion)

TABLE 5. Global Microparticle Injectables Market estimates & forecasts by Distribution Channel 2019-2028 (USD Billion)

TABLE 6. Global Microparticle Injectables Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 7. Global Microparticle Injectables Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 8. Global Microparticle Injectables Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 9. Global Microparticle Injectables Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 10. Global Microparticle Injectables Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 11. Global Microparticle Injectables Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 12. Global Microparticle Injectables Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 13. Global Microparticle Injectables Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 14. Global Microparticle Injectables Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 15. Global Microparticle Injectables Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 16. U.S. Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 17. U.S. Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 18. U.S. Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 19. Canada Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 20. Canada Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 21. Canada Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 22. UK Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 23. UK Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 24. UK Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 25. Germany Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 26. Germany Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 27. Germany Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 28. RoE Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 29. RoE Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 30. RoE Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 31. China Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 32. China Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 33. China Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 34. India Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 35. India Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 36. India Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 37. Japan Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 38. Japan Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 39. Japan Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 40. RoAPAC Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 41. RoAPAC Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 42. RoAPAC Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 43. Brazil Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 44. Brazil Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 45. Brazil Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 46. Mexico Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 47. Mexico Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 48. Mexico Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 49. RoLA Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 50. RoLA Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 51. RoLA Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 52. Row Microparticle Injectables Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 53. Row Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 54. Row Microparticle Injectables Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global Microparticle Injectables Market

TABLE 56. List of primary sources, used in the study of global Microparticle Injectables Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research